Vaxil Bio Ltd.
Financial ratios & Valuation

Historical Multiples (2012 – 2023)

2012 2015 2016 2017 2018 2019 2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
-1.04-1.15-0.86-2.52-2.43-2.67-22.29-10.35-4.69-13.48K-3.96-2.67
Price/Sales ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Price/Book Value ratio
2.06-5.706.00-9.305.87-5.3337.966.002.413.842.10-5.33
Price/Cash Flow ratio
-1.18-1.98-2.63-4.52-2.70-5.22-27.67-9.41-3.73-6.10-4.00-4.00
Price/Free Cash Flow ratio
-1.11-1.98-2.95-4.52-2.70-5.22-27.67-9.41-3.73-6.10-4.00-4.00
Price/Earnings Growth ratio
0.600.03-0.020.030.03-0.41-7.300.220.11134.84-0.33-0.41
Dividend Yield
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Operating Profit Margin
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Pretax Profit Margin
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Net Profit Margin
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Effective Tax Rate
N/A-0.27%-2.20%0.27%-0.57%-0.95%-0.80%N/AN/AN/AN/A-0.57%
Return on Assets
-142.99%-370%-372.96%-580%-117.64%-568.29%-82.42%-43.15%-37.89%-0.02%-40.19%-117.64%
Return On Equity
-196.69%494.47%-691.92%369.19%-240.68%199.82%-170.27%-57.99%-51.40%-0.02%-45.98%-240.68%
Return on Capital Employed
-196.90%493.08%-614.72%411.64%-239.31%199.82%-167.53%-57.99%-51.40%-28.50%-53.07%-239.31%
Liquidity Ratios
Current Ratio
0.41N/A2.200.251.810.141.90N/AN/AN/A4.121.81
Quick Ratio
0.210.522.200.251.810.141.903.903.8011.484.121.81
Cash ratio
0.090.022.140.221.650.101.763.833.7211.034.041.65
Days of Sales Outstanding
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Days of Inventory outstanding
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Operating Cycle
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Days of Payables Outstanding
4.021.58K4.54K1.63K2.18K1.71K3.76K8.1671.90N/AN/A1.71K
Cash Conversion Cycle
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Debt Ratios
Debt Ratio
0.27N/AN/AN/AN/A-0.43N/AN/AN/AN/A0.24-0.43
Debt Equity Ratio
0.37N/AN/AN/AN/A0.15N/AN/AN/AN/A0.320.15
Long-term Debt to Capitalization
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Total Debt to Capitalization
N/AN/AN/AN/AN/A0.13N/AN/AN/AN/AN/A0.13
Interest Coverage Ratio
N/AN/A-448.9360.6N/A-103.90-122.45N/AN/AN/AN/A-103.90
Cash Flow to Debt Ratio
N/AN/AN/AN/AN/A6.62N/AN/AN/AN/AN/A6.62
Company Equity Multiplier
1.37-1.331.85-0.632.04-0.352.061.341.351.091.32-0.35
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Free Cash Flow / Operating Cash Flow Ratio
1.0610.89111111111
Cash Flow Coverage Ratio
N/AN/AN/AN/AN/A6.62N/AN/AN/AN/AN/A6.62
Short Term Coverage Ratio
N/AN/AN/AN/AN/A6.62N/AN/AN/AN/AN/A6.62
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A